Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate

Author： Dávila-Fajardo Cristina Lucía   Swen Jesse J   Cabeza Barrera José   Guchelaar Henk-Jan  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.1, 2013-01, pp. : 63-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genetic association studies in drug-induced liver injury

By Daly Ann K.   Day Christopher P.  

Drug Metabolism Reviews, Vol. 44, Iss. 1, 2012-02 ,pp. : 116-126

Informa Healthcare

Access to resources Recommend Favorite

Drug-Induced Liver Injury

By Abboud Gebran   Kaplowitz Neil  

Drug Safety, Vol. 30, Iss. 4, 2007-01 ,pp. : 277-294

Adis International

Access to resources Recommend Favorite

Drug-induced liver injury: what was new in 2008?

By Liss Gordon   Lewis James H  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 843-860

Informa Healthcare

Access to resources Recommend Favorite

Drug-induced liver injury: a summary of recent advances

By Stine Jonathan G   Lewis James H  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 875-890

Informa Healthcare

Access to resources Recommend Favorite

Drug-induced liver injury: past, present and future

By Daly Ann K  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 607-611

Future Medicine

Access to resources Recommend Favorite